505
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Isolation and characterization of N98-1272 A, B and C, selective acetylcholinesterase inhibitors from metabolites of an actinomycete strain

, , , , , , & show all
Pages 43-49 | Received 03 May 2006, Accepted 30 Jul 2006, Published online: 04 Oct 2008
 

Abstract

A high throughput screening was carried out in order to search for inhibitors of acetylcholinesterase (AChE) from microorganism metabolites. An actinomycete strain was found to produce active compounds named N98-1272 A, B and C with IC50 of 15.0, 11.5, 12.5 μM, respectively. Structural studies revealed that the three compounds are identical to the known antibiotics, Manumycin C, B and A. Kinetic analyses showed that N98-1272 C (Manumycin A) acted as a reversible noncompetitive inhibitor of acetylcholinesterase, with a Ki value of 7.2 μM. The cyclohexenone epoxide part of the structure plays a crucial role in the inhibitory activity against AChE. Compared with Tacrine, N98-1272 A, B, and C exhibit much better selectivity toward AChE over BuChE.

Acknowledgements

This work was supported by the Chinese Ministry of Science and Technology in Mega-projects of Science Research for the 10th Five-Year Plan (Grant No. 2002AA2Z343D). We wish to express our thanks to Professor Yanchang Wang and Professor Randy Rill (Department of Biomedical Sciences, College of Medicine, Florida State University, U.S.A), Dr. Shaun K. Olsen and Dr. Yong Xie (Riken, Yokohama Institute, Japan) for their help in English revision and valuable suggestions.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.